Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Dec 18, 2020
Date Accepted: Jan 31, 2021
Date Submitted to PubMed: Mar 16, 2021

The final, peer-reviewed published version of this preprint can be found here:

Artificial Intelligence–Enabled Analysis of Public Attitudes on Facebook and Twitter Toward COVID-19 Vaccines in the United Kingdom and the United States: Observational Study

Hussain A, Tahir A, Hussain Z, Sheikh Z, Dashtipour K, Ali A, Sheikh A

Artificial Intelligence–Enabled Analysis of Public Attitudes on Facebook and Twitter Toward COVID-19 Vaccines in the United Kingdom and the United States: Observational Study

J Med Internet Res 2021;23(4):e26627

DOI: 10.2196/26627

PMID: 33724919

PMCID: 8023383

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Artificial intelligence-enabled analysis of UK and US public attitudes on Twitter and Facebook towards COVID-19 vaccination

  • Amir Hussain; 
  • Ahsen Tahir; 
  • Zain Hussain; 
  • Zakariya Sheikh; 
  • Kia Dashtipour; 
  • Azhar Ali; 
  • Aziz Sheikh

ABSTRACT

Background:

Global efforts towards the development and deployment of a vaccine for SARS-CoV-2 are rapidly advancing. We developed and applied an artificial-intelligence (AI)-based approach to analyse social-media public sentiment in the UK and the US towards COVID-19 vaccinations, to understand public attitude and identify topics of concern.

Methods:

Over 300,000 social-media posts related to COVID-19 vaccinations were extracted, including 23,571 Facebook-posts from the UK and 144,864 from the US, along with 40,268 tweets from the UK and 98,385 from the US respectively, from 1st March - 22nd November 2020. We used natural-language processing and deep learning-based techniques to predict average sentiments, sentiment trends and topics of discussion. These were analysed longitudinally and geo-spatially, and a manual- eading of randomly selected posts around points of interest helped identify underlying themes and validated insights from the analysis.

Results:

We found overall averaged positive, negative and neutral sentiment in the UK to be 58%, 22% and 17%, compared to 56%, 24% and 18% in the US, respectively. Public optimism over vaccine development, effectiveness and trials as well as concerns over safety, economic viability and corporation control were identified. We compared our findings to national surveys in both countries and found them to correlate broadly.

Conclusions:

AI-enabled social-media analysis should be considered for adoption by institutions and governments, alongside surveys and other conventional methods of assessing public attitude. This could enable real-time assessment, at scale, of public confidence and trust in COVID-19 vaccinations, help address concerns of vaccine-sceptics and develop more effective policies and communication strategies to maximise uptake.


 Citation

Please cite as:

Hussain A, Tahir A, Hussain Z, Sheikh Z, Dashtipour K, Ali A, Sheikh A

Artificial Intelligence–Enabled Analysis of Public Attitudes on Facebook and Twitter Toward COVID-19 Vaccines in the United Kingdom and the United States: Observational Study

J Med Internet Res 2021;23(4):e26627

DOI: 10.2196/26627

PMID: 33724919

PMCID: 8023383

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.